Detecting, Sequencing and/or Mapping 5-Hydroxymethylcytosine and 5-Formylcytosine at Single-Base Resolution

• US 20160194696A1
• Filed: 08/07/2014
• Published: 07/07/2016
• Est. Priority Date: 08/09/2013
• Status: Abandoned Application

• Current Assignee: New England Biolabs Incorporated
• Original Assignee: New England Biolabs Incorporated
• Inventors: Guan, Shengxi, Zhu, Zhenyu, Sun, Zhiyi, Dai, Nan
• Application Number:
  US14/911,094
• Publication Number:
  US 20160194696A1
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: C12N 15/1003 Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
• CPC Class Codes: C12N 15/1093 General methods of preparing gene libraries, not provided for in other subgroups
• CPC Class Codes: C12Q 1/6806 Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 1/6872 involving mass spectrometry
• CPC Class Codes: C12Q 2521/501 Ligase
• CPC Class Codes: C12Q 2523/301 Sonication
• CPC Class Codes: C12Q 2531/113 PCR
• CPC Class Codes: C12Q 2535/122 Massive parallel sequencing
• CPC Class Codes: C12Q 2537/164 Methylation detection other then bisulfite or methylation sensitive restriction endonucleases

Abstract

This disclosure describes, among other things, compositions, kits and methods for identifying to 5-hydroxymethylcytosine (5hmC) in eukaryotic genomic DNA. The compositions and methods utilize a PvuRts1I family enzyme for digesting eukaryotic genomic DNA suspected of containing 5hmC or 5-formylcytosine (5fC) modified nucleotides providing an end of the DNA with a two base overhang suitable for ligating an adapter at a fixed distance 3′ from an 5hmC. Random fragmentation of the genomic DNA can generate a blunt end suitable for attaching a second adapter. The DNA can be sequenced and 5hmC and 5fC residues identified and located at a defined position in the eukaryotic genome. An enrichment step may be used that utilizes a chemoselective agent capable of being selectively added to DNA containing 5hmC. An example is a glucosyltransferase and a glucosyltransferase substrate comprising a chemo-selective group. This DNA can then be enriched by immobilization on a matrix that binds the chemoselective agent added to the DNA containing 5hmC and DNA that does not contain a chemo-selective group is removed by washing. Adapters can be added at one or both ends of the restriction endonuclease cleaved DNA after random fragmentation prior to or after an enrichment step.

Claims

1. A preparation comprising a PvuRts1I-family bacterial restriction endonuclease and a eukaryotic DNA having at least one 5-hydroxymethylcytosine (5hmC).

2. A preparation according to claim 1 wherein the molar ratio of the bacterial restriction endonuclease to 5-hydroxymethylcytosine (5hmC) in the eukaryotic DNA is at least 0.5:

1.

3. A preparation according to claim 1, further comprising a glucosyltransferase and a glucosyltransferase substrate that comprises a chemo-selective group.

4. A preparation according to claim 1, further comprising, an adapter having at least a two nucleotide 3′

overhang of random sequence and a 5′

phosphate for ligating to the eukaryotic DNA.

5. A method for detecting 5-hydroxymethylcytosine (5hmC) in a sample, comprising:

(a) digesting eukaryotic genomic DNA comprising 5hmC using a preparation according to claim 1, to form a DNA having a first end, wherein the first end has a single strand overhang;

the eukaryotic genomic DNA being randomly fragmented (i) prior to restriction endonuclease digestion, or (ii) after restriction endonuclease digestion;

(b) ligating an adapter to the first end; and

(c) detecting the presence and the position of 5hmC in the eukaryotic genomic DNA using DNA sequences determined for the adaptor ligated DNA.

6. The method of claim 5, further comprising selectively adding a chemoselective group to the 5-hydroxymethylcytosine (5hmC) in the DNA prior to (c).

7. The method according to claim 6, wherein selectively adding the chemoselective group comprises reacting the DNA with a glucosyltransferase and a glucosyltransferase substrate.

8. The method according to claim 6, further comprising reacting the added chemoselective group with a capture molecule that comprises an affinity moiety and optionally a cleavable linker;

capturing the DNA that comprise the affinity moiety on a matrix; and

releasing the captured DNA from the matrix.

9. The method according to claim 8, wherein releasing the captured DNA comprises cleaving the cleavable linker.

10. The method according to claim 8, wherein the cleavable linker is a disulfide bond, and the cleaving comprises reducing the disulfide bond.

11. The method according to claim 8, wherein the affinity moiety is a biotin moiety.

12. A method according to claim 6, wherein selectively adding the chemoselective group to 5-hydroxymethylcytosine (5hmC) further comprises increasing the reaction temperature to 37°

C.

13. A method according to claim 5, wherein (a) further comprises, digesting the eukaryotic genomic DNA with the restriction endonuclease at a temperature below 37°

C.

14. A method according to claim 5, further comprising:

combining the PvuRts1I-family restriction endonuclease, a glucosyltransferase, a glucosyltransferase substrate and the eukaryotic genomic DNA in a single reaction vessel.

15. A method according to claim 5, further comprising removing restriction endonuclease activity prior to ligating the adapter.

16. A method according to claim 13, further comprising heat inactivating the restriction endonuclease.

17. The method according to claim 5 wherein an amount of the restriction endonuclease corresponds to a molar ratio of the restriction endonuclease to total 5-hydroxymethylcytosine (5hmC) in the eukaryotic DNA of at least 0.5:

1.

18. The method according to claim 1, wherein the first end is characterized by a 3′

two base overhang on a strand of the eukaryotic genomic DNA having a 5-hydroxymethylcytosine (5hmC).

19. The method according to claim 18, wherein the overhang is a two nucleotide overhang of random sequence.

20. The method according to claim 1, further comprising randomly fragmenting the digestion products into DNA fragments having a size of less than 500 bases.

21. The method according to claim 5, wherein the eukaryotic DNA has a second end, the method comprising adding a second adapter to the second end for amplifying the eukaryotic DNA between the adapters at the first end and the second end.

22. The method according to claim 5, further comprising (d) annotating a cytosine as being a 5-hydroxymethylcytosine (5hmC) or 5-formylcytosine (5fC) in the eukaryotic genomic DNA.

23. The method according to claim 5, further comprising treating the eukaryotic DNA with NaBH₄ prior to (a).

24. A kit comprising a PvuRts1I-family restriction endonuclease, a glucosyltransferase and a glucosyltransferase substrate that comprises a chemo-selective group and a buffer and instructions for use at an initial temperature of room temperature followed by an incubation at 37°

C.